Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ik-Kyung Jang, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ik-Kyung Jang and Robert Yeh.
Connection Strength

2.626
  1. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv. 2009 Aug 01; 74(2):359-64.
    View in: PubMed
    Score: 0.426
  2. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21.
    View in: PubMed
    Score: 0.343
  3. Argatroban: update. Am Heart J. 2006 Jun; 151(6):1131-8.
    View in: PubMed
    Score: 0.342
  4. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging. 2013 Sep; 6(5):665-73.
    View in: PubMed
    Score: 0.141
  5. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012 Nov; 5(11):1150-8.
    View in: PubMed
    Score: 0.133
  6. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012 Oct 01; 110(7):933-9.
    View in: PubMed
    Score: 0.130
  7. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography. J Am Coll Cardiol. 2012 Jun 12; 59(24):2218-9.
    View in: PubMed
    Score: 0.130
  8. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012 Jul; 5(4):433-40.
    View in: PubMed
    Score: 0.130
  9. Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period. J Thromb Thrombolysis. 2010 Oct; 30(3):276-80.
    View in: PubMed
    Score: 0.115
  10. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):116-20.
    View in: PubMed
    Score: 0.099
  11. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention? Blood Coagul Fibrinolysis. 2008 Jul; 19(5):401-4.
    View in: PubMed
    Score: 0.099
  12. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8.
    View in: PubMed
    Score: 0.094
  13. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome. J Thromb Thrombolysis. 2008 Apr; 25(2):214-8.
    View in: PubMed
    Score: 0.092
  14. Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography. J Heart Lung Transplant. 2007 May; 26(5):478-84.
    View in: PubMed
    Score: 0.090
  15. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7.
    View in: PubMed
    Score: 0.090
  16. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol. 2006 Oct 01; 98(7):877-84.
    View in: PubMed
    Score: 0.087
  17. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7.
    View in: PubMed
    Score: 0.086
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.